Shoulder pain, which is the third most common cause of musculoskeletal pain, has different etiologies. Muscle, bone structures and connective tissue pathologies can cause shoulder pain. Impingement syndrome (IS), which can cover many terms such as rotator cuff disorders, tendinitis and tears, is one of the most common pathologies of shoulder pain.
The hypothesis of this study was that injection types including ACJ would increase treatment efficacy.Therefore, this study investigated the six-month follow-up results of patients undergoing SA injection and SSNB and those receiving SA and ACJ injection.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
88
5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area
5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area for the subacromial+acromioclavicular joint injection. In addition, 2 mL of 20 mg methylprednisolone and the same concentration of local anaesthetic were injected into the acromioclavicular joint
suprascapular nerve block was administered with a mixture of 10 mL of 0.25% bupivacaine and 40 mg methylprednisolone
Visual Analogue Scale (VAS)
for pain. 0: no pain at all, 10: worst pain imaginable
Time frame: six month
Shoulder pain and disability index (SPADI)
This scale was developed to measure pain and disability associated with shoulder pain. It consists of two parts evaluating pain and disability.
Time frame: six month
Short-Form 12 (SF-12)
The SF-12 has a physical (SF12-PCS) and mental (SF12-MCS) state assessment scale
Time frame: six month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.